The Lancet. Infectious diseases
A partner protection package for HIV cure-related trials involving analytical treatment interruptions.
Advancing detection and response capacities for emerging and re-emerging pathogens in Africa.
New boosters are here! Who should receive them and when?
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study.
Has artemisinin resistance emerged in Africa?
Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity.
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies.
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.
Improving the cascade of global tuberculosis care: moving from the "what" to the "how" of quality improvement.
